We are live on ! Find out more
BCOV

Brightcove, Inc.

Delisted

BCOV was delisted on the 3rd of February, 2025.

109 hedge funds and large institutions have $226M invested in Brightcove, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

12% more capital invested

Capital invested by funds: $202M → $226M (+$23.8M)

5% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 41

14% less funds holding

Funds holding: 127109 (-18)

50% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 22

87% less call options, than puts

Call options by funds: $191K | Put options by funds: $1.45M

Holders
109
Holders Change
-18
Holders Change %
-14.17%
% of All Funds
2.71%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
11
Increased
39
Reduced
41
Closed
22
Calls
$191K
Puts
$1.45M
Net Calls
-$1.26M
Net Calls Change
-$420K
Name Holding Trade Value Shares
Change
Change in
Stake
SRFM
26
Shannon River Fund Management
New York
$2.16M +$1.93M +242,752 New
Two Sigma Investments
27
Two Sigma Investments
New York
$2.05M -$354K -44,605 -16%
Jacobs Levy Equity Management
28
Jacobs Levy Equity Management
New Jersey
$2.01M +$58.8K +7,400 +3%
GCP
29
GSA Capital Partners
United Kingdom
$2.01M +$256K +32,270 +17%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$2M +$16.6K +2,093 +0.9%
OAM
31
Oxford Asset Management
United Kingdom
$1.98M -$554K -69,691 -24%
MAG
32
Millrace Asset Group
Pennsylvania
$1.77M +$1.58M +198,442 New
BLA
33
Balter Liquid Alternatives
Massachusetts
$1.74M +$585K +73,603 +60%
Morgan Stanley
34
Morgan Stanley
New York
$1.66M -$537K -67,552 -27%
TCIM
35
TIAA CREF Investment Management
New York
$1.56M +$314K +39,511 +29%
RHJA
36
Rice Hall James & Associates
California
$1.55M +$151K +19,025 +12%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.48M -$20.1K -2,532 -1%
GH
38
GAM Holding
Switzerland
$1.38M -$12.7K -1,600 -1%
SIM
39
Spark Investment Management
New York
$1.28M -$1.02M -128,100 -47%
KI
40
Kalmar Investments
Delaware
$1.2M -$212K -26,720 -17%
Bank of America
41
Bank of America
North Carolina
$1.19M +$404K +50,811 +61%
EIM
42
Essex Investment Management
Massachusetts
$1.18M +$256K +32,178 +32%
MC
43
Menta Capital
California
$1.14M -$110K -13,800 -10%
Prudential Financial
44
Prudential Financial
New Jersey
$1.08M +$16.7K +2,100 +2%
State of New Jersey Common Pension Fund D
45
State of New Jersey Common Pension Fund D
New Jersey
$1.07M
Federated Hermes
46
Federated Hermes
Pennsylvania
$936K +$34.7K +4,367 +4%
GC
47
Globeflex Capital
California
$921K -$187K -23,600 -19%
DCM
48
Dupont Capital Management
Delaware
$834K
BIM
49
Bogle Investment Management
Massachusetts
$823K -$479K -60,312 -39%
CCM
50
Concourse Capital Management
Georgia
$789K +$704K +88,625 New

BCOV Hedge Fund Activity: Q1 2017 in Review

109 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Brightcove, Inc. (BCOV) for Q1 2017, worth a combined $226M — up 12% from $202M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of BCOV and 11 opened new positions — a net loss of 11 holders — while 41 trimmed existing stakes and 39 added.

The largest buyer was BlackRock, adding an estimated $14.6M. The largest seller was Formula Growth, exiting entirely with an estimated $4.27M sold.

  • 109 institutional investors held Brightcove, Inc. (BCOV) as of Q1 2017, down from 127 in Q4 2016.
  • Funds reported $226M of Brightcove, Inc. stock for Q1 2017, up 12% quarter-over-quarter.
  • 11 funds opened new Brightcove, Inc. positions in Q1 2017 and 22 closed out, a net change of -11 holders.
  • The largest Brightcove, Inc. buyer in Q1 2017 was BlackRock, an estimated $14.6M added.
  • The largest Brightcove, Inc. seller in Q1 2017 was Formula Growth, an estimated $4.27M sold.

Based on aggregated 13F filings for Q1 2017.